On 22 November 2018, Hong Kong Science and Technology Parks Corporation organized a press-release for GeneHarbor to announce a full chain of Enzymatic Technology for Bio-Manufacturing. Named Immobilised Enzyme Assembly for Cascade Biocatalysis, the biotech platform uses newly-developed industrial enzymes, proprietary technologies and groundbreaking enzyme-based manufacturing processes to develop drugs and food ingredients for various industries. After the announcement, the media visited GeneHarbor’s R&D centre at Hong Kong Science Park.